Circulating tumor DNA sequencing of pediatric solid and brain tumor patients: An institutional feasibility study.

Autor: Mangum R; Center for Cancer and Blood Disorders, Phoenix Children's Hospital, Phoenix, Arizona, USA., Reuther J; Department of Pathology & Immunology, Baylor College of Medicine, Houston, Texas, USA., Sen Baksi K; Texas Children's Cancer Center, Department of Pediatrics, Baylor College of Medicine, Houston, Texas, USA., Gandhi I; Department of Pathology & Immunology, Baylor College of Medicine, Houston, Texas, USA., Zabriskie RC; Texas Children's Cancer Center, Department of Pediatrics, Baylor College of Medicine, Houston, Texas, USA., Recinos A; Texas Children's Cancer Center, Department of Pediatrics, Baylor College of Medicine, Houston, Texas, USA., Raesz-Martinez R; Texas Children's Cancer Center, Department of Pediatrics, Baylor College of Medicine, Houston, Texas, USA., Lin FY; Texas Children's Cancer Center, Department of Pediatrics, Baylor College of Medicine, Houston, Texas, USA.; The Dan L. Duncan Cancer Center, Baylor College of Medicine, Houston, Texas, USA., Potter SL; The Steve and Cindy Rasmussen Institute for Genomic Medicine, Nationwide Children's Hospital, Columbus, Ohio, USA.; Department of Pediatrics, The Ohio State University, Columbus, Ohio, USA., Sher AC; Department of Radiology, Texas Children's Hospital, Houston, Texas, USA., Kralik SF; Department of Radiology, Texas Children's Hospital, Houston, Texas, USA., Mohila CA; Department of Pathology & Immunology, Baylor College of Medicine, Houston, Texas, USA.; Department of Pathology, Texas Children's Hospital, Houston, Texas, USA., Chintagumpala MM; Texas Children's Cancer Center, Department of Pediatrics, Baylor College of Medicine, Houston, Texas, USA.; The Dan L. Duncan Cancer Center, Baylor College of Medicine, Houston, Texas, USA., Muzny D; Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas, USA.; The Human Genome Sequencing Center, Baylor College of Medicine, Houston, Texas, USA., Hu J; Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas, USA.; The Human Genome Sequencing Center, Baylor College of Medicine, Houston, Texas, USA., Gibbs RA; Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas, USA.; The Human Genome Sequencing Center, Baylor College of Medicine, Houston, Texas, USA., Fisher KE; Department of Pathology & Immunology, Baylor College of Medicine, Houston, Texas, USA.; The Dan L. Duncan Cancer Center, Baylor College of Medicine, Houston, Texas, USA.; Department of Pathology, Texas Children's Hospital, Houston, Texas, USA., Bernini JC; Texas Children's Cancer Center, Department of Pediatrics, Baylor College of Medicine, Houston, Texas, USA., Gill J; Division of Pediatrics, University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Griffin TC; Department of Hematology Oncology, The Children's Hospital of San Antonio, Baylor College of Medicine, San Antonio, Texas, USA., Tomlinson GE; Greehey Children's Cancer Research Institute, UT Health San Antonio, San Antonio, Texas, USA., Vallance KL; Hematology and Oncology, Cook Children's Medical Center, Fort Worth, Texas, USA., Plon SE; Texas Children's Cancer Center, Department of Pediatrics, Baylor College of Medicine, Houston, Texas, USA.; The Dan L. Duncan Cancer Center, Baylor College of Medicine, Houston, Texas, USA.; Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas, USA.; The Human Genome Sequencing Center, Baylor College of Medicine, Houston, Texas, USA., Roy A; Department of Pathology & Immunology, Baylor College of Medicine, Houston, Texas, USA.; Texas Children's Cancer Center, Department of Pediatrics, Baylor College of Medicine, Houston, Texas, USA.; The Dan L. Duncan Cancer Center, Baylor College of Medicine, Houston, Texas, USA.; Department of Pathology, Texas Children's Hospital, Houston, Texas, USA., Parsons DW; Texas Children's Cancer Center, Department of Pediatrics, Baylor College of Medicine, Houston, Texas, USA.; The Dan L. Duncan Cancer Center, Baylor College of Medicine, Houston, Texas, USA.; Department of Pathology, Texas Children's Hospital, Houston, Texas, USA.; Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas, USA.; The Human Genome Sequencing Center, Baylor College of Medicine, Houston, Texas, USA.

Publikováno v: Pediatric hematology and oncology [Pediatr Hematol Oncol] 2023; Vol. 40 (8), pp. 719-738. Date of Electronic Publication: 2023 Jun 27.

Family-based exome-wide assessment of maternal genetic effects on susceptibility to childhood B-cell acute lymphoblastic leukemia in hispanics.

Autor: Archer NP; Austin Regional Campus, University of Texas School of Public Health, Austin, Texas., Perez-Andreu V; Department of Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, Tennessee.; Hematologic Malignancies Program, Comprehensive Cancer Center, St. Jude Children's Research Hospital, Memphis, Tennessee., Scheurer ME; Section of Hematology-Oncology, Department of Pediatrics, Baylor College of Medicine, Houston, Texas., Rabin KR; Section of Hematology-Oncology, Department of Pediatrics, Baylor College of Medicine, Houston, Texas., Peckham-Gregory EC; Section of Hematology-Oncology, Department of Pediatrics, Baylor College of Medicine, Houston, Texas., Plon SE; Section of Hematology-Oncology, Department of Pediatrics, Baylor College of Medicine, Houston, Texas., Zabriskie RC; Section of Hematology-Oncology, Department of Pediatrics, Baylor College of Medicine, Houston, Texas., De Alarcon PA; Department of Pediatrics, University of Illinois College of Medicine at Peoria, Peoria, Illinois., Fernandez KS; Department of Pediatrics, University of Illinois College of Medicine at Peoria, Peoria, Illinois., Najera CR; National Pediatric Oncology Unit, Guatemala City, Guatemala., Yang JJ; Department of Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, Tennessee.; Hematologic Malignancies Program, Comprehensive Cancer Center, St. Jude Children's Research Hospital, Memphis, Tennessee., Antillon-Klussmann F; National Pediatric Oncology Unit, Guatemala City, Guatemala.; School of Medicine, Francisco Marroquin University, Guatemala City, Guatemala., Lupo PJ; Section of Hematology-Oncology, Department of Pediatrics, Baylor College of Medicine, Houston, Texas.

Publikováno v: Cancer [Cancer] 2016 Dec 01; Vol. 122 (23), pp. 3697-3704. Date of Electronic Publication: 2016 Aug 16.

Mesenchymal stem cells from the Wharton's jelly of umbilical cord segments provide stromal support for the maintenance of cord blood hematopoietic stem cells during long-term ex vivo culture.

Autor: Bakhshi T; Division of Maternal-Fetal Medicine, The University of Texas Medical School at Houston, Houston, Texas, USA., Zabriskie RC, Bodie S, Kidd S, Ramin S, Paganessi LA, Gregory SA, Fung HC, Christopherson KW 2nd

Publikováno v: Transfusion [Transfusion] 2008 Dec; Vol. 48 (12), pp. 2638-44. Date of Electronic Publication: 2008 Sep 16.

Human umbilical cord blood mononuclear cells transplantation for perinatal brain injury.

Autor: Xi, Yufeng¹ (AUTHOR), Yue, Guang¹ (AUTHOR), Gao, Shuqiang¹ (AUTHOR), Ju, Rong¹ (AUTHOR) jurong123@126.com, Wang, Yujia^1,2 (AUTHOR) 15881424997@163.com

Publikováno v: Stem Cell Research & Therapy. 9/5/2022, Vol. 13 Issue 1, p1-8. 8p.

The preclinical and clinical implications of fetal adnexa derived mesenchymal stromal cells in wound healing therapy.

Autor: Mankuzhy, Pratheesh D.¹, Ramesh, Sreekumar T.¹, Thirupathi, Yasotha², Mohandas, Ponny S.³, Chandra, Vikash², Sharma, Taru Guttula² gts553@gmail.com

Publikováno v: Wound Repair & Regeneration. May2021, Vol. 29 Issue 3, p347-369. 23p.